Cognitive behavior therapy for obsessive compulsive disorder in youth: a narrative review

Cognitive behavior therapy for obsessive compulsive disorder in youth: a narrative review

Tiffany Field, PhD

University of Miami School of Medicine and Fielding Graduate University

This narrative review is organized around the primary symptoms of obsessive compulsive disorder (OCD) including physical and cognitive symptoms and the effectiveness of cognitive behavior therapy (CBT) in reducing these symptoms in youth with an OCD diagnosis. These are followed by sections on the comorbidities of OCD including anxiety and depression, the effective delivery of CBT via both internet and in-person, the greater effectiveness of CBT versus pharmacotherapy, the use of alternative therapies and the negative effects of COVID-19 on both OCD and CBT. The review concludes with limitations of the literature and suggested future directions

Keywords: Cognitive behavior therapy;  Oobsessive compulsive disorder; Youth

Free Full-text PDF

How to cite this article:

Tiffany Field. Cognitive behavior therapy for obsessive compulsive disorder in youth: a narrative reviewl. American Journal of Psychiatric Research and Reviews, 2022; 5:37. DOI: 10.28933/ajprr-2022-07-2006tf1

References

1. Aspvall K, Andersson E, Melin K, Norlin L, Eriksson V, Vigerland S, Jolstedt M, Silverberg-Mörse M, Wallin L, Sampaio F, Feldman I, Bottai M, Lenhard F, Mataix-Cols D, Serlachius E. Effect of an Internet-Delivered Stepped-Care Program vs In-Person Cognitive Behavioral Therapy on Obsessive-Compulsive Disorder Symptoms in Children and Adolescents: A Randomized Clinical Trial. JAMA. 2021 May 11;325(18):1863-1873. doi: 10.1001/jama.2021.3839. PMID: 33974020; PMCID: PMC8114140.
2. Bora A, Uzun Cicek A. Olfactory Impairment in Children and Adolescents With Obsessive-Compulsive Disorder. J Nerv Ment Dis. 2020 Nov;208(11):890-896. doi: 10.1097/NMD.0000000000001231. PMID: 32925693.
3. Esnafoğlu E, Yaman E. Vitamin B12, folic acid, homocysteine and vitamin D levels in children and adolescents with obsessive compulsive disorder. Psychiatry Res. 2017 Aug;254:232-237. doi: 10.1016/j.psychres.2017.04.032. Epub 2017 Apr 21. PMID: 28477545.
4. Field, T. Yoga therapy research: A narrative review. Journal of Yoga and Physiotherapy.2020 8, 49-71.
5. Geller DA, Homayoun S, Johnson G. Developmental Considerations in Obsessive Compulsive Disorder: Comparing Pediatric and Adult-Onset Cases. Front Psychiatry. 2021 Jun 14;12:678538. doi: 10.3389/fpsyt.2021.678538. PMID: 34248714; PMCID: PMC8269156.
6. Hezel DM, Simpson HB. Exposure and response prevention for obsessive-compulsive disorder: A review and new directions. Indian J Psychiatry. 2019 Jan;61(Suppl 1):S85-S92. doi: 10.4103/psychiatry.IndianJPsychiatry_516_18. PMID: 30745681; PMCID: PMC6343408.
7. Hoppen LM, Kuck N, Bürkner PC, Karin E, Wootton BM, Buhlmann U. Low intensity technology-delivered cognitive behavioral therapy for obsessive-compulsive disorder: a meta-analysis. BMC Psychiatry. 2021 Jun 30;21(1):322. doi: 10.1186/s12888-021-03272-5. PMID: 34193113; PMCID: PMC8243493.
8. Ivarsson T, Melin K, Carlsson Å, Ljungberg M, Forssell-Aronsson E, Starck G, Skarphedinsson G. Neurochemical properties measured by 1H magnetic resonance spectroscopy may predict cognitive behaviour therapy outcome in paediatric OCD: a pilot study. J Neural Transm (Vienna). 2021 Sep;128(9):1361-1370. doi: 10.1007/s00702-021-02407-y. Epub 2021 Aug 20. PMID: 34415439.
9. Johnco C, McGuire JF, Roper T, Storch EA. A meta-analysis of dropout rates from exposure with response prevention and pharmacological treatment for youth with obsessive compulsive disorder. Depress Anxiety. 2020 May;37(5):407-417. doi: 10.1002/da.22978. Epub 2019 Nov 28. PMID: 31778595.
10. Kahn L, Sutton B, Winston HR, Abosch A, Thompson JA, Davis RA. Deep Brain Stimulation for Obsessive-Compulsive Disorder: Real World Experience Post-FDA-Humanitarian Use Device Approval. Front Psychiatry. 2021 Mar 24;12:568932. doi: 10.3389/fpsyt.2021.568932. PMID: 33868034; PMCID: PMC8044872.
11. KotapatiVP, Khan AM, Dar S, Begum G, Bachu R, Adnan M, Zubair A, Ahmed RA. The Effectiveness of Selective Serotonin Reuptake Inhibitors for Treatment of Obsessive-Compulsive Disorder in Adolescents and Children: A Systematic Review and Meta-Analysis. Front Psychiatry. 2019 Aug 6;10:523. doi: 10.3389/fpsyt.2019.00523. PMID: 31447707; PMCID: PMC6691487.
12. Külz AK, Landmann S, Cludius B, Rose N, Heidenreich T, Jelinek L, Alsleben H, Wahl K, Philipsen A, Voderholzer U, Maier JG, Moritz S. Mindfulness-based cognitive therapy (MBCT) in patients with obsessive-compulsive disorder (OCD) and residual symptoms after cognitive behavioral therapy (CBT): a randomized controlled trial. Eur Arch Psychiatry Clin Neurosci. 2019 Mar;269(2):223-233. doi: 10.1007/s00406-018-0957-4. Epub 2018 Nov 16. PMID: 30446822.
13. Lovell K, Bower P, Gellatly J, Byford S, Bee P, McMillan D, Arundel C, Gilbody S, Gega L, Hardy G, Reynolds S, Barkham M, Mottram P, Lidbetter N, Pedley R, Molle J, Peckham E, Knopp-Hoffer J, Price O, Connell J, Heslin M, Foley C, Plummer F, Roberts C. Low-intensity cognitive-behaviour therapy interventions for obsessive-compulsive disorder compared to waiting list for therapist-led cognitive-behaviour therapy: 3-arm randomised controlled trial of clinical effectiveness. PLoS Med. 2017 Jun 27;14(6):e1002337. doi: 10.1371/journal.pmed.1002337. PMID: 28654682; PMCID: PMC5486961.
14. Mahjani B, Bey K, Boberg J, Burton C. Genetics of obsessive-compulsive disorder. Psychol Med. 2021 Oct;51(13):2247-2259. doi: 10.1017/S0033291721001744. Epub 2021 May 25. PMID: 34030745; PMCID: PMC8477226.
15. McCathern AG, Mathai DS, Cho RY, Goodman WK, Storch EA. Deep transcranial magnetic stimulation for obsessive compulsive disorder. Expert Rev Neurother. 2020 Oct;20(10):1029-1036. doi: 10.1080/14737175.2020.1798232. Epub 2020 Aug 1. PMID: 32684005.
16. Miniksar DY, Özdemir M. Sleep quality in children and adolescents with obsessive-compulsive disorders. Nord J Psychiatry. 2021 Jan;75(1):25-30. doi: 10.1080/08039488.2020.1785005. Epub 2020 Jul 9. PMID: 32646260.
17. Rector NA, Richter MA, Katz D, Leybman M. Does the addition of cognitive therapy to exposure and response prevention for obsessive compulsive disorder enhance clinical efficacy? A randomized controlled trial in a community setting. Br J Clin Psychol. 2019 Mar;58(1):1-18. doi: 10.1111/bjc.12188. Epub 2018 Jul 8. PMID: 29984550.
18. Richter PMA, Ramos RT. Obsessive-Compulsive Disorder. Continuum (Minneap Minn). 2018 Jun;24(3, BEHAVIORAL NEUROLOGY AND PSYCHIATRY):828-844. doi: 10.1212/CON.0000000000000603. PMID: 29851880.
19. Rozenman M, Piacentini J, O’Neill J, Bergman RL, Chang S, Peris TS. Improvement in anxiety and depression symptoms following cognitive behavior therapy for pediatric obsessive compulsive disorder. Psychiatry Res. 2019 Jun;276:115-123. doi: 10.1016/j.psychres.2019.04.021. Epub 2019 Apr 19. PMID: 31075706; PMCID: PMC7197731.
20. Schneider SC, Knott L, Cepeda SL, Hana LM, McIngvale E, Goodman WK, Storch EA. Serious negative consequences associated with exposure and response prevention for obsessive-compulsive disorder: A survey of therapist attitudes and experiences. Depress Anxiety. 2020 May;37(5):418-428. doi: 10.1002/da.23000. Epub 2020 Feb 12. PMID: 32048376.
21. Schröder J, Werkle N, Cludius B, Jelinek L, Moritz S, Westermann S. Unguided Internet-based cognitive-behavioral therapy for obsessive-compulsive disorder: A randomized controlled trial. Depress Anxiety. 2020 Dec;37(12):1208-1220. doi: 10.1002/da.23105. Epub 2020 Nov 10. PMID: 33169490.
22. Stein DJ, Costa DLC, Lochner C, Miguel EC, Reddy YCJ, Shavitt RG, van den Heuvel OA, Simpson HB. Obsessive-compulsive disorder. Nat Rev Dis Primers. 2019 Aug 1;5(1):52. doi: 10.1038/s41572-019-0102-3. PMID: 31371720; PMCID: PMC7370844.
23. Storch EA, Sheu JC, Guzick AG, Schneider SC, Cepeda SL, Rombado BR, Gupta R, Hoch CT, Goodman WK. Impact of the COVID-19 pandemic on exposure and response prevention outcomes in adults and youth with obsessive-compulsive disorder. Psychiatry Res. 2021 Jan;295:113597. doi: 10.1016/j.psychres.2020.113597. Epub 2020 Nov 26. PMID: 33261922; PMCID: PMC7688422.
24. Sulaimani MF, Bagadood NH. Implication of coronavirus pandemic on obsessive-compulsive-disorder symptoms. Rev Environ Health. 2020 Aug 31;36(1):1-8. doi: 10.1515/reveh-2020-0054. PMID: 32866131.
25. Tang VM, Blumberger DM, Weissman CR, Dimitrova J, Throop A, McClintock SM, Voineskos D, Rajji TK, Downar J, Knyahnytska Y, Mulsant BH, Fitzgerald PB, Daskalakis ZJ. A pilot study of magnetic seizure therapy for treatment-resistant obsessive-compulsive disorder. Depress Anxiety. 2021 Feb;38(2):161-171. doi: 10.1002/da.23097. Epub 2020 Sep 19. PMID: 32949052.
26. Tao Y, Li H, Li L, Zhang H, Xu H, Zhang H, Zou S, Deng F, Huang L, Wang Y, Wang X, Tang X, Fu X, Yin L. Comparing the efficacy of pharmacological and psychological treatment, alone and in combination, in children and adolescents with obsessive-compulsive disorder: A network meta-analysis. J Psychiatr Res. 2022 Apr;148:95-102. doi: 10.1016/j.jpsychires.2022.01.057. Epub 2022 Jan 29. PMID: 35121274.
27. Uhre CF, Uhre VF, Lønfeldt NN, Pretzmann L, Vangkilde S, Plessen KJ, Gluud C, Jakobsen JC, Pagsberg AK. Systematic Review and Meta-Analysis: Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder in Children and Adolescents. J Am Acad Child Adolesc Psychiatry. 2020 Jan;59(1):64-77. doi: 10.1016/j.jaac.2019.08.480. Epub 2019 Oct 4. PMID: 31589909.
28. Wang M, Han B, Liu Q, Liu C, Li W, Teng S, Du H, Huang S, Kong H, Lu G, Song Y. Attentional bias of subliminal emotional faces in adolescents with obsessive-compulsive disorder. Neurocase. 2021 Feb;27(1):22-29. doi: 10.1080/13554794.2020.1861303. Epub 2020 Dec 30. PMID: 33378225.
29. Wergeland GJH, Riise EN, Öst LG. Cognitive behavior therapy for internalizing disorders in children and adolescents in routine clinical care: A systematic review and meta-analysis. Clin Psychol Rev. 2021 Feb;83:101918. doi: 10.1016/j.cpr.2020.101918. Epub 2020 Sep 23. PMID: 33186776.
30. Wheaton MG, Gallina ER. Using Cognitive-Behavioral Therapy to Treat Obsessive-Compulsive Disorder With Co-Occurring Depression. J Cogn Psychother. 2019 Aug 1;33(3):228-241. doi: 10.1891/0889-8391.33.3.228. PMID: 32746429.
31. Wolters LH, Prins PJM, Garst GJA, Hogendoorn SM, Boer F, Vervoort L, de Haan E. Mediating Mechanisms in Cognitive Behavioral Therapy for Childhood OCD: The Role of Dysfunctional Beliefs. Child Psychiatry Hum Dev. 2019 Apr;50(2):173-185. doi: 10.1007/s10578-018-0830-8. PMID: 30032391; PMCID: PMC6428795.